ENZALUTAMIDE HAS PROVED SURVIVAL BENEFIT IN 1ST & 2ND LINES IN MCRPC
Scher HI, et al. N Engl J Med 2012;367(13):1187-97
Beer TM, et al. N Engl J Med 2014;371:424-33